In this review, we focus specifically on how maternal immune activation (MIA) — induced by infections, autoimmune diseases, or other immune challenges during pregnancy — affects fetal brain development via the P2X7/NLRP3/IL-1β signalling axis. Here, P2RX7 is linked to autoimmune disease.